https://www.selleckchem.com/products/Nolvadex.html
Although the dichotomous classification of metabolic syndrome (MS) enables the classification of individuals as MS-free or presenting MS, it is inconvenient for assessing cardiometabolic risk in MS-free ones. Continuous MS score allows for estimation of cardiometabolic burden even in MS-free subjects. We used the scores to estimate the proportion of MS-free subjects on high cardiometabolic risk. 876 subjects (62% females) of Central European descent, aged 20-81 years, were included. IDF criteria were employed to classify MS. Continuous
Like
Comment
Share
